Latanoprost/timolol fixed combination for the treatment of glaucoma


Konstas A. G. P. , MOCAN M. C. , Katsanos A., Voudouragkaki I. C. , Irkec M.

EXPERT OPINION ON PHARMACOTHERAPY, vol.14, no.13, pp.1815-1827, 2013 (Journal Indexed in SCI) identifier identifier

  • Publication Type: Article / Review
  • Volume: 14 Issue: 13
  • Publication Date: 2013
  • Doi Number: 10.1517/14656566.2013.813482
  • Title of Journal : EXPERT OPINION ON PHARMACOTHERAPY
  • Page Numbers: pp.1815-1827

Abstract

Introduction: Glaucoma is a multifactorial optic neuropathy that can lead to progressive and irreversible loss of vision. Today there are > 60 million glaucoma patients worldwide, and this figure is rising due to aging. The aim of glaucoma therapy is to maintain the patient's visual function and quality of life by means of intraocular pressure (IOP) reduction, which currently constitutes the only evidence-based approach.